Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT00324805
Status:
COMPLETED
Last Update Posted:
2025-03-03
First Post:
2006-05-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2015-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-10
First Submit QC Date:
None
Study First Post Date:
2006-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-12
Results First Submit QC Date:
None
Results First Post Date:
2018-02-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-28
Last Update Post Date:
2025-03-03
Last Update Post Date Type:
ACTUAL